Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion type Assertion NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_head.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion evidence source_evidence_literature NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion SIO_000772 21289371 NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion wasDerivedFrom befree-2016 NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.
- NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_assertion wasGeneratedBy ECO_0000203 NP869883.RA64Zc-N0qgYIDRBmz4bAmdTb3jn-tUfZips-j1Nx1j54130_provenance.